In poster #2, we showed the initial studies conducted in the labs of PLS for Version 2 LymPro, using a total number of 44 patients. The data showed that using the best cell type response (CD4 cells), we achieved an accuracy of 81%. Beyond that single data point, accuracy readings for the next best responses had accuracy ratings individually between 70% and 80%. These are univariate results, not using any statistical modeling methods at all. The reason why we are so happy with this, beyond the specific 81% number in the topline section, is because what this is showing, without any shadow of a doubt, is that CCD is clearly a critical component of the disease, and we are able to identify it with high statistical significance across all cell types tested of interest in the blood. - See more at:

http://www.thechairmansblog.com/amarantus-bio...ZDsDl.dpuf